Sun Pharma to test pancreatitis drug in Covid-19 patients in India3Photo© timesofindia.indiatimes.com

Sun Pharma to test pancreatitis drug in Covid-19 patients in India

, 11 news, 2 views

Drugmaker Sun Pharmaceutical Industries Ltd said on Friday it has received Indian regulatory approval to start clinical trials of a pancreatitis drug in Covid-19 patients.

The company joins other Indian drugmakers Glenmark Pharmaceuticals Ltd and Strides Pharma Science Ltd that are conducting trials in India for potential drugs for Covid-19, which currently has no approved treatment or vaccine.

Sun Pharma said here the pancreatitis drug, nafamostat mesilate, has been "identified as a potential candidate for Covid-19 patients by scientists at University of Tokyo and Leibniz Institute for Primate Research, Germany".